SB-258,719

Из Википедије, слободне енциклопедије
SB-258,719
SB-258719 structure.png
IUPAC ime
(1R)-3,N-dimetil-N-[1-metil-3-(4-metilpiperidin-1-il)propil]benzenesulfonamid
Identifikatori
CAS broj 195199-95-2 ДаY
ATC kod none
PubChem CID 5312148
ChemSpider 4471578 ДаY
ChEMBL CHEMBL12264 ДаY
Hemijski podaci
Formula C18H32N2O2S
Molarna masa 340,523 g/mol
  (verify)

SB-258,719 je lek koji deluje kao selektivni parcijalni inverzni agonist 5-HT7 receptora.[1] On je bio prvi identifikovani antagonist 5-HT7 receptora.[2] On se uglavnom upotrebljan u istraživanjima za demonstriranje potencijalne uloge 5-HT7 agonista kao potencijalnih analgetika, usled njegove sposobnosti da blokira analgetičke efekte raznih 5-HT7 agonista u miše modela.[3][4][5][6]

Reference[уреди]

  1. Mahé C, Loetscher E, Feuerbach D, Müller W, Seiler MP, Schoeffter P (2004). „Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors”. European Journal of Pharmacology 495 (2-3): 97—102. doi:10.1016/j.ejphar.2004.05.033. PMID 15249157. 
  2. Forbes IT, Dabbs S, Duckworth DM, Jennings AJ, King FD, Lovell PJ, Brown AM, Collin L, Hagan JJ, Middlemiss DN, Riley GJ, Thomas DR, Upton N (1998). „(R)-3,N-dimethyl-N-[1-methyl-3-(4-methyl-piperidin-1-yl) propyl]benzenesulfonamide: the first selective 5-HT7 receptor antagonist”. Journal of Medicinal Chemistry 41 (5): 655—7. doi:10.1021/jm970519e. PMID 9513592. 
  3. Brenchat A, Romero L, García M, Pujol M, Burgueño J, Torrens A, Hamon M, Baeyens JM, Buschmann H, Zamanillo D, Vela JM (2009). „5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice”. Pain 141 (3): 239—47. doi:10.1016/j.pain.2008.11.009. PMID 19118950. 
  4. Yanarates O, Dogrul A, Yildirim V, Sahin A, Sizlan A, Seyrek M, Akgül O, Kozak O, Kurt E, Aypar U (2010). „Spinal 5-HT7 receptors play an important role in the antinociceptive and antihyperalgesic effects of tramadol and its metabolite, O-Desmethyltramadol, via activation of descending serotonergic pathways”. Anesthesiology 112 (3): 696—710. doi:10.1097/ALN.0b013e3181cd7920. PMID 20179508. 
  5. Brenchat A, Nadal X, Romero L, Ovalle S, Muro A, Sánchez-Arroyos R, Portillo-Salido E, Pujol M, Montero A, Codony X, Burgueño J, Zamanillo D, Hamon M, Maldonado R, Vela JM (2010). „Pharmacological activation of 5-HT7 receptors reduces nerve injury-induced mechanical and thermal hypersensitivity”. Pain 149 (3): 483—94. doi:10.1016/j.pain.2010.03.007. PMID 20399562. 
  6. Brenchat A, Ejarque M, Zamanillo D, Vela JM, Romero L (2011). „Potentiation of Morphine Analgesia by Adjuvant Activation of 5-HT(7) Receptors”. Journal of Pharmacological Sciences 116 (4): 388—91. PMID 21778664. 

Spoljašnje veze[уреди]